Tradestie Institutional Equity Comparison Engine

MLTX vs PRAX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PRAX Overall Edge

PRAX Captures Institutional Edge (3โ€“0 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Praxis Precision Medicines, Inc. Common Stock (PRAX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MLTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PRAX at N/M Forward P/E and 0.0% operating margin (+1349.1% YoY). In options structure, MLTX sits in BREAKDOWN (7th %ile IV; Dealer Gamma Walls on Pro) against PRAX sits in CONSOLIDATION (4th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MLTX N/M vs PRAX N/M Fwd P/E
Growth & Margin Winner PRAX
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +1349.1%
Momentum & Technical Winner PRAX
1Y -5.7% vs +73.6% ยท 52W Pos 17% vs 64%
Options & Structure Winner PRAX
BREAKDOWN (7th %ile IV) vs CONSOLIDATION (4th %ile IV)
MLTX NASDAQ
MoonLake Immunotherapeutics Class A Ordinary Shares
Pharmaceutical Preparations
$11.85
-5.2% 1D
Market Cap $1.1B
1M Return +24.08%
1Y Return -5.65%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 32.0 Fund 44.0 Flow 75.0 Mom 50.0
PRAX NASDAQ
Praxis Precision Medicines, Inc. Common Stock
Pharmaceutical Preparations
$309.08
-5.81% 1D
Market Cap $9.1B
1M Return +27.85%
1Y Return +73.56%
Forward P/E N/M
Unified AI Score
34.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 71.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MLTX -5.65% PRAX +73.56% Spread: +79.21 pp (PRAX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MLTX TTM Op. Margin: 0.0% PRAX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MLTX vs PRAX. Trailing 12-month operating profitability (MLTX 0.0% vs PRAX 0.0%) and valuation multiples (MLTX N/M vs PRAX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MLTX (2) vs PRAX (4)
Institutional Metric MLTX PRAX Criterion Row Winner
Market Capitalization Scale $1.1B $9.1B Larger Scale PRAX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +1349.1% Higher Growth PRAX
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -81.5% -44.8% Higher ROE PRAX
52-Week Range Position Momentum 17% ($9โ€“$23) 64% ($160โ€“$393) Stronger Trend PRAX
Beta / 30D Volatility Risk Regime 1.61ฮฒ ยท 90% Vol 1.79ฮฒ ยท 93% Vol Lower Realized Risk MLTX
Unified Institutional Score Composite Signal 38.3 / 100 (SELL) 34.6 / 100 (SELL) Higher Composite MLTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MLTX vs PRAX Buy Guide
MLTX BREAKDOWN
103d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MLTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PRAX CONSOLIDATION
67d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live PRAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MLTX nor PRAX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.